SUBSCRIBE
SUBSCRIBE
Bio NC

Targeted Therapy After Chemo Ups Survival in NSCLC, University of North Carolina Study

May 20, 2010 | 
1 min read

MedPage Today -- Maintenance therapy with erlotinib (Tarceva) immediately after successful first-line chemotherapy improves outcomes in non-small cell lung cancer (NSCLC), researchers affirmed.

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Sequence’s new training facility/Sequence
Job Trends
New Training Models Address Workforce Gap in Biopharma Manufacturing
September 20, 2023
 · 
4 min read
 · 
Jennifer Markarian
Courtesy of Getty Images
Business
Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM
January 10, 2023
 · 
2 min read
 · 
Lisa Munger